Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?-Reference-Cited by-同舟云学术

Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?

Published:2017-09-18 Issue:1 Volume:153 Page:51-59
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Jansen Manon A. A.¹^ORCID,Spiering Rachel²³⁴,Broere Femke¹,van Laar Jacob M.⁵,Isaacs John D.²³⁴,van Eden Willem¹,Hilkens Catharien M. U.²³⁴

Affiliation:

1. Division of Immunology; Department of Infectious Diseases and Immunology; Utrecht University; the Netherlands

2. Musculoskeletal Research Group; Institute of Cellular Medicine; Newcastle University; Newcastle upon Tyne UK

3. Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of Excellence (RACE); UK UK

4. NIHR-Newcastle Biomedical Research Centre in Ageing and Long-Term Conditions; Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University; Newcastle upon Tyne UK

5. Department of Rheumatology & Clinical Immunology; UMC Utrecht; Utrecht the Netherlands

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imm.12811/fullpdf

Reference93 articles.

1. Regulatory T cells: how do they suppress immune responses?;Sakaguchi;Int Immunol,2009

2. The therapeutic potential of regulatory T cells for the treatment of autoimmune disease;Bluestone;Expert Opin Ther Targets,2015

3. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3;Bennett;Nat Genet,2001

4. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes;Brusko;Diabetes,2005

5. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4+ CD25+ regulatory T-cells of type 1 diabetic subjects;Long;Diabetes,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis;BMJ Open;2024-09

2. Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines;Frontiers in Immunology;2024-03-06

3. Cold in Biology and Medicine: state of the art and perspectives;2023

4. From vaccines to nanovaccines: A promising strategy to revolutionize rheumatoid arthritis treatment;Journal of Controlled Release;2022-10

5. Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search;Rheumatology;2022-03-03